MedPath
HSA Approval

VINRACINE INJ. 1 mg/ml

SIN10319P

VINRACINE INJ. 1 mg/ml

VINRACINE INJ. 1 mg/ml

October 29, 1998

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

L01CA02

vincristine

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

KOREA UNITED PHARMACEUTICAL INC

Active Ingredients

VINCRISTINE SULPHATE

1 mg/ml

Vincristine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.